Sanofi
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · France · 10K+ Employees
View Company Info for Free
Overview
Headquarters
46 Avenue De La Grande Armee, Paris, Île...Phone Number
+33153774000Website
www.sanofi.comRevenue
$54.2 BillionStock Symbol
SNYIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
4
3
3
2
1
About Sanofi
Sanofi is a global biopharmaceutical company dedicated to improving lives through scientific innovation. The company focuses on discovering, developing, and delivering medicines and vaccines across immunology, rare diseases, neurology, oncology, and preventive care. Guided by research and patient needs, it works with healthcare partners worldwide to advance sustainable and responsible healthcare solutions.Explore more
Sanofi Org Chart
YN
Chief Financial Officer (South Korea, Austral...
LS
Chief Financial Officer, & Fbp General Medici...
MG
Contralor
MN
Site Controller
MV
Financial Controller
SP
Expense Management Controller
HL
Senior Financial Controller & Planning Analys...
JS
LATAM & Cf Controller (Brazil)
KD
Director of Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sanofi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Sanofi has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Sanofi has new funding data
Congratulate Masked Content for being promoted to Masked Content at Sanofi
Click to see if Sanofi had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Sanofi recently announced quarterly report
Sanofi, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Sanofi launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Sanofi is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Explore company insights
Get a deeper look into Sanofi's structure, leadership, and market position:
Company Profile Activity
Activity Insights
Sanofi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sanofi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sanofi.
Sanofi Tech Stack
A closer look at the technologies used by Sanofi
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Sanofi News & Media
Sanofi Boasts a Dividend Yield of 5.4%, Trades Below 9x Earnings, and Just Got an FDA Win. Are Income Investors Missing a Rare Opportunity?
The company has increased its dividend for 30 consecutive years.Sanofi (ENXTPA:SAN) On TD Cowen Spotlight And The Case For A Higher Valuation
Sanofi stock reaction to TD Cowen conference spotlight on immunology and rare diseases Sanofi (ENXTPA:SAN) is set to present at the TD Cowen Hot Wheels Tour in New York on 12 August 2026, with senior leaders highlighting its immunology, inflammation, and rare disease franchises. For investors watching Sanofi stock, the focus will be on how management frames the role of immunology and rare blood disorder development within its broader biopharma business, and what this mightSanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition
In the first major workforce reduction disclosed under new CEO Belén Garijo, Sanofi is laying off 229 employees from legacy Blueprint Medicines in Massachusetts as part of a post-acquisition integr | In the first major workforce reduction disclosed under new CEO Belén Garijo, Sanofi is laying off 229 employees from legacy Blueprint Medicines in Massachusetts as part of a post-acquisition integration.Sanofi to lay off 229 workers in Mass., a year after $9.1 billion biotech acquisition
The layoffs were disclosed just over a year after Sanofi acquired Blueprint Medicines.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sanofi
Sign Up For FreeTo access detailed company insights
Sanofi is a global biopharmaceutical company dedicated to improving lives through scientific innovation. The company focuses on discovering, developing, and delivering medicines and vaccines across immunology, rare diseases, neurology, oncology, and preventive care. Guided by research and patient needs, it works with healthcare partners worldwide t... Read More
